BREAKING: Intismeran with Keytruda is the first and only combination to demonstrate statistically significant and clinically meaningful improvements in RFS and DMFS compared to KEYTRUDA alone for patients in the adjuvant melanoma setting.
So happy for our patients and our field!
Congratulations to Dr. @eckhoff_austin!
The Vail Workshop Award supports SSO fellows attending the AACR/ASCO Methods in Clinical Cancer Research Workshop, a program featuring mentorship, career development, and hands-on clinical trial protocol development.
Dr. @michael_lidsky has been appointed Section Chief of HPB Surgery @DukeSurgOnc, effective July 10! Since 2018, he’s built one of the world’s highest-volume HAIP programs & mentored countless trainees, now on faculty nationwide. Congrats, Dr. Lidsky! 👏
#SurgOnc#DukeSurgery
🎙️ Proud of our own former @DukeSurgRes Resident, Dr. Nellie Farrow (now @EmoryMedicine)! Check out her new @SocSurgOnc micro-learning on MSLT-3 & melanoma paradigm shifts with Dr. Mark Faries of Cedar Sinai. #SurgOnc
https://t.co/uFGy6r64lU
Counting down the weekends left in Durham! Amazing race through some of my favorite downtown spots to say goodbye to my home for the last 11 years #runningofthebulls8k
Amazing turnout for the 36th Hilliard Seigler Duke Melanoma and Skin Cancer Consortium! Congrats Georgia Beasley and April Salama for putting together an outstanding program! @DukeSurgOnc@DukeCancer@DukeSurgery
Reminder to join us this Friday, May 15th at the Annual Hilliard Seigler Melanoma Consortium! An educational event for patients and families with updates on cutaneous oncology @DukeSurgery@DukeCancer https://t.co/76gjjVHUmD
Excellent session at #SSO2026 on the current state and future of Neoadjuvant Immunotherapy in melanoma and beyond - featuring methods and challenges to monitoring response by our own Dr. Georgia Beasley! @DukeCancer@DukeSurgery